IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Prostate Cancer and Prostatic Diseases

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

4.15

h-Index

2023-2024

 78

Rank

2023-2024

 1787

SJR

2023-2024

 1.711

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Prostate Cancer and Prostatic Diseases
Abbreviation Prostate Cancer Prostatic Dis.
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q1); Oncology (Q1); Urology (Q1)
h-index 78
Overall Rank/Ranking 1787
SCImago Journal Rank (SJR) 1.711
Impact Score 4.15
Publisher Nature Publishing Group
Country United Kingdom
ISSN 13657852, 14765608
Best Quartile Q1
Coverage History 1997-2023




About Prostate Cancer and Prostatic Diseases


Prostate Cancer and Prostatic Diseases is a journal covering the technologies/fields/categories related to Cancer Research (Q1); Oncology (Q1); Urology (Q1). It is published by Nature Publishing Group. The overall rank of Prostate Cancer and Prostatic Diseases is 1787. According to SCImago Journal Rank (SJR), this journal is ranked 1.711. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 78. The best quartile for this journal is Q1.

The ISSN of Prostate Cancer and Prostatic Diseases journal is 13657852, 14765608. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Prostate Cancer and Prostatic Diseases is cited by a total of 1550 articles during the last 3 years (Preceding 2023).


Prostate Cancer and Prostatic Diseases Impact IF 2023-2024


The Impact IF 2023 of Prostate Cancer and Prostatic Diseases is 4.15, which is computed in 2024 as per its definition. Prostate Cancer and Prostatic Diseases IF is decreased by a factor of 0.48 and approximate percentage change is -10.37% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prostate Cancer and Prostatic Diseases Impact IF 2024 Prediction


Impact IF 2023 of Prostate Cancer and Prostatic Diseases is 4.15. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Prostate Cancer and Prostatic Diseases. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 4.15
2022 4.63
2021 5.42
2020 4.27
2019 4.00
2018 4.92
2017 4.60
2016 4.22
2015 4.10
2014 3.75

Prostate Cancer and Prostatic Diseases h-index


  Table Setting

Prostate Cancer and Prostatic Diseases has an h-index of 78. It means 78 articles of this journal have more than 78 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Prostate Cancer and Prostatic Diseases ISSN


The ISSN of Prostate Cancer and Prostatic Diseases is 13657852, 14765608. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Prostate Cancer and Prostatic Diseases Rank and SCImago Journal Rank (SJR)


The overall rank of Prostate Cancer and Prostatic Diseases is 1787. According to SCImago Journal Rank (SJR), this journal is ranked 1.711. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Prostate Cancer and Prostatic Diseases by Year


Year SJR
2023/2024 Coming Soon
2023 1.711
2022 1.676
2021 1.519
2020 2.000
2019 1.830
2018 2.200
2017 2.149
2016 1.904
2015 1.693
2014 1.723

Ranking of Prostate Cancer and Prostatic Diseases by Year


Year Ranking
2023/2024 Coming Soon
2023 1787
2022 1765
2021 2050
2020 1307
2019 1535
2018 1157
2017 1218
2016 1552
2015 1939
2014 1827

Prostate Cancer and Prostatic Diseases Publisher


Table Setting

Prostate Cancer and Prostatic Diseases is published by Nature Publishing Group. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1997-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Prostate Cancer and Prostatic Diseases is Prostate Cancer Prostatic Dis.. This abbreviation ('Prostate Cancer Prostatic Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Prostate Cancer and Prostatic Diseases


If your research field is/are related to Cancer Research (Q1); Oncology (Q1); Urology (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Prostate Cancer and Prostatic Diseases?

Prostate Cancer and Prostatic Diseases latest impact IF is 4.15. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.42 (2021) and 3.75 (2014), respectively, in the last 10 years. Moreover, its average IS is 4.41 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases has an SJR (SCImago Journal Rank) of 1.711, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.200 in 2018 and the lowest being 1.519 in 2021. Furthermore, the average SJR of the Prostate Cancer and Prostatic Diseases over the previous 10-year period stands at 4.41.


What's the latest h-index of the Prostate Cancer and Prostatic Diseases?

The latest h-index of the Prostate Cancer and Prostatic Diseases is 78.


Who's the publisher of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases is published by the Nature Publishing Group, with its country of publication being the United Kingdom.


What's the current ranking of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases is currently ranked 1787 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1157 in 2018 and its lowest position of 2050 in 2021.


What's the abbreviation or short name for the Prostate Cancer and Prostatic Diseases?

The standard ISO4 abbreviation for the Prostate Cancer and Prostatic Diseases is Prostate Cancer Prostatic Dis..


Is the "Prostate Cancer and Prostatic Diseases" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Prostate Cancer and Prostatic Diseases is classified as a journal that the Nature Publishing Group publishes.


What's the scope or major areas of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases encompasses the following areas:

  • Cancer Research
  • Oncology
  • Urology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases is assigned the following International Standard Serial Numbers (ISSN): 13657852, 14765608.


What's the best quartile of the Prostate Cancer and Prostatic Diseases?

The best quartile for the Prostate Cancer and Prostatic Diseases is Q1 (2023).


What's the coverage history of the Prostate Cancer and Prostatic Diseases?

The Prostate Cancer and Prostatic Diseases coverage history can be summarized as follows: 1997-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Canadian Journal of Education journal 18985 Canadian Society for the Study of Education (CSSE) 43 0.58
Abacus journal 5997 Wiley-Blackwell Publishing Ltd 53 2.75
Modern Language Journal journal 1100 Wiley-Blackwell 112 3.93
Proceedings of the Technical Association of the Graphic Arts, TAGA conference and proceedings 30903 Technical Association of the Graphic 8 0.00
Indian Phytopathology journal 15501 Springer Nature 16 1.09
Museum Management and Curatorship journal 10406 Routledge 40 1.72
SPE International Formation Damage Control Symposium Proceedings conference and proceedings 21934 16 0.00
Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria journal 25905 National Association of Resident Doctors of Nigeria 25 0.00
Transactions on Embedded Computing Systems journal 5892 Association for Computing Machinery (ACM) 64 2.87
Clinical Interventions in Aging journal 5314 Dove Medical Press Ltd. 104 3.55

Check complete list




Year wise Impact Score (IS) of Prostate Cancer and Prostatic Diseases

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 4.15
2022 4.63
2021 5.42
2020 4.27
2019 4.00
2018 4.92
2017 4.60
2016 4.22
2015 4.10
2014 3.75



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Molecular Cancer
BioMed Central Ltd | United Kingdom

JAMA Oncology
American Medical Association | United States

Cell Host and Microbe
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Lancet Oncology, The
Elsevier Ltd | United Kingdom

Nature Cancer
Nature Research | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Journal of Thoracic Oncology
Elsevier Inc. | United States

See All

Top Journals/Conferences in Urology

Lancet Neurology, The
Elsevier Ltd | United Kingdom

European Urology
Elsevier B.V. | Netherlands

Neuro-Oncology
Oxford University Press | United Kingdom

Nature Reviews Neurology
Nature Publishing Group | United Kingdom

JAMA Neurology
American Medical Association | United States

Molecular Neurodegeneration
BioMed Central Ltd | United Kingdom

Acta Neuropathologica
Springer Science and Business Media Deutschland GmbH | Germany

Brain
Oxford University Press | United Kingdom

Annals of Neurology
John Wiley & Sons Inc. | United States

Sleep Medicine Reviews
W.B. Saunders Ltd | United Kingdom

See All